Showing results (451-460 of 634) with videos related to

Sort By:
Pageof 64
International Journal of Radiation Oncology, Biology, Physics|March 18, 2009
lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapyYoung Seok Kim, Jong Hoon Kim, Sang Min Yoon, et al.
Oncology|September 10, 2009
The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patientsByeong Seok Sohn, Tae Won Kim, Jae-Lyun Lee, et al.
Cancer Research and Treatment|September 23, 2009
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors of the stomach: report of three casesJi Seon Oh, Jae-Lyun Lee, Mi-Jung Kim, et al.
Surgical Oncology|September 5, 2020
Lateral lymph node and its association with distant recurrence in rectal cancer: A clue of systemic diseaseYoung Il Kim, Jong Keon Jang, In Ja Park, et al.
Antioxidants (Basel, Switzerland)|October 26, 2024
Silibinin Suppresses Inflammatory Responses Induced by Exposure to Asian Sand DustSe-Jin Lee, So-Won Pak, Woong-Il Kim, et al.
Clinical Colorectal Cancer|August 6, 2018
Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront SurgeryChung Ryul Oh, Jeong Eun Kim, Jihoon Kang, et al.
Nature Medicine|January 25, 2025
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trialScott Kopetz, Takayuki Yoshino, Eric Van Cutsem, et al.
Biomaterials Research|December 11, 2025
Gelatin-Based Soft-Tissue Sarcoma Organoids Recapitulate Patient Tumor CharacteristicsKyuyoung Han, Jiwan Choi, Chae-Eun Kim, et al.
Clinical Colorectal Cancer|April 29, 2018
Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal CancerTae Won Kim, Anneli Elme, Joon Oh Park, et al.
American Journal of Cancer Research|April 12, 2022
Expression of SLC22A18 regulates oxaliplatin resistance by modulating the ERK pathway in colorectal cancerTae Won Kim, Dae Hee Pyo, Eunbyeol Ko, et al.
Pageof 64